Back to VA VANGUARD CAPITAL MANAGEMENT LLC

MAIAMAIA
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in MAIA BIOTECHNOLOGY INC

Yes. Vanguard Capital Management holds 2,413,270 shares of MAIA (Maia Biotechnology), worth $3.5M, as of its Q2 2026 13F filing. It increased the position by 339,225 shares (+16.4%) from Q1 2026. Vanguard Capital Management has held MAIA in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$3.5M

Current Shares

2.4M

Total Value Change

+$571,446

Total Shares Change

+339,225

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.4M
+16.4%
$3.5M0.0%$1.44
31
2026-Q1
First report
2.1M
-
$2.9M0.0%$1.51
0

Other major holders of MAIA: Alyeska Investment Group, L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used